Dynatronics (NASDAQ:DYNT) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Dynatronics (NASDAQ:DYNTGet Rating) in a report issued on Thursday. The firm set a “hold” rating on the medical equipment provider’s stock.

A number of other equities analysts have also recently issued reports on DYNT. Roth Capital restated a “buy” rating on shares of Dynatronics in a report on Thursday, February 17th. TheStreet lowered Dynatronics from a “c-” rating to a “d+” rating in a research report on Friday, February 11th. Finally, Zacks Investment Research raised Dynatronics from a “sell” rating to a “hold” rating in a research report on Wednesday, April 13th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $2.13.

Dynatronics stock opened at $0.66 on Thursday. The business’s 50-day simple moving average is $0.72 and its 200 day simple moving average is $0.96. The stock has a market cap of $11.84 million, a price-to-earnings ratio of 7.33 and a beta of -0.01. Dynatronics has a 12-month low of $0.65 and a 12-month high of $1.79. The company has a quick ratio of 1.30, a current ratio of 2.38 and a debt-to-equity ratio of 0.12.

Dynatronics (NASDAQ:DYNTGet Rating) last posted its quarterly earnings results on Thursday, February 10th. The medical equipment provider reported ($0.09) earnings per share (EPS) for the quarter. Dynatronics had a net margin of 4.50% and a return on equity of 12.52%. The firm had revenue of $10.53 million during the quarter. During the same quarter last year, the company posted ($0.06) EPS. As a group, sell-side analysts expect that Dynatronics will post -0.21 EPS for the current year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Citadel Advisors LLC acquired a new stake in Dynatronics in the 3rd quarter valued at approximately $30,000. Goldman Sachs Group Inc. acquired a new stake in Dynatronics in the 3rd quarter valued at approximately $56,000. Millennium Management LLC acquired a new stake in Dynatronics in the 3rd quarter valued at approximately $120,000. Finally, Renaissance Technologies LLC raised its position in Dynatronics by 36.8% in the 4th quarter. Renaissance Technologies LLC now owns 1,096,365 shares of the medical equipment provider’s stock valued at $1,096,000 after buying an additional 295,200 shares during the last quarter. 19.46% of the stock is currently owned by institutional investors.

Dynatronics Company Profile (Get Rating)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products.

Read More

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.